Pulmonx (LUNG) Accounts Payables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Accounts Payables data on file, last reported at $3.9 million in Q4 2025.

• On a quarterly basis, Accounts Payables rose 2.04% year-over-year to $3.9 million in Q4 2025; TTM through Dec 2025 was $3.9 million, a 2.04% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, up 2.04% from the prior year.
• Accounts Payables for Q4 2025 stood at $3.9 million, down from $6.4 million in the prior quarter.
• Over the last five years, Accounts Payables for LUNG reached as high as $6.6 million in Q2 2025 and fell as low as $1.5 million in Q4 2023.
• Historically, Accounts Payables has averaged $3.3 million across 5 years, with a median of $3.0 million in 2023.
• Across the five-year window, Accounts Payables plunged 40.28% in 2022 and jumped 155.64% in 2024, its largest moves.
• Year by year, Accounts Payables stood at $1.6 million in 2021, then increased by 11.13% to $1.8 million in 2022, then dropped by 14.85% to $1.5 million in 2023, then soared by 155.64% to $3.8 million in 2024, then climbed by 2.04% to $3.9 million in 2025.
• Per Business Quant data, the three most recent Accounts Payables figures were $3.9 million in Q4 2025, $6.4 million in Q3 2025, and $6.6 million in Q2 2025.